IL232851A0 - Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases - Google Patents

Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases

Info

Publication number
IL232851A0
IL232851A0 IL232851A IL23285114A IL232851A0 IL 232851 A0 IL232851 A0 IL 232851A0 IL 232851 A IL232851 A IL 232851A IL 23285114 A IL23285114 A IL 23285114A IL 232851 A0 IL232851 A0 IL 232851A0
Authority
IL
Israel
Prior art keywords
nox4
inhibitors
treating
chronic diseases
nadph oxidase
Prior art date
Application number
IL232851A
Other languages
Hebrew (he)
Original Assignee
Yeda Res & Dev
Rubinstein Menachem
Dvash Riesenfeld Efrat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Rubinstein Menachem, Dvash Riesenfeld Efrat filed Critical Yeda Res & Dev
Priority to IL232851A priority Critical patent/IL232851A0/en
Publication of IL232851A0 publication Critical patent/IL232851A0/en
Priority to CN201580020281.XA priority patent/CN106456999A/en
Priority to PCT/IL2015/050183 priority patent/WO2015125137A1/en
Priority to PCT/IL2015/050184 priority patent/WO2015125138A1/en
Priority to US15/118,196 priority patent/US20170172979A1/en
Priority to EP15751737.6A priority patent/EP3107626A4/en
Priority to JP2016552577A priority patent/JP2017510558A/en
Priority to IL247334A priority patent/IL247334A0/en
Priority to US15/798,530 priority patent/US20180064682A1/en

Links

IL232851A 2014-02-19 2014-05-28 Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases IL232851A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL232851A IL232851A0 (en) 2014-05-28 2014-05-28 Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases
CN201580020281.XA CN106456999A (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
PCT/IL2015/050183 WO2015125137A1 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene mediated activity for alleviating chemotherapy side effects and stress induced cell death
PCT/IL2015/050184 WO2015125138A1 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
US15/118,196 US20170172979A1 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
EP15751737.6A EP3107626A4 (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
JP2016552577A JP2017510558A (en) 2014-02-19 2015-02-18 Inhibitors of leukotriene-mediated activity to treat the side effects of statin therapy
IL247334A IL247334A0 (en) 2014-02-19 2016-08-17 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy
US15/798,530 US20180064682A1 (en) 2014-02-19 2017-10-31 Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL232851A IL232851A0 (en) 2014-05-28 2014-05-28 Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases

Publications (1)

Publication Number Publication Date
IL232851A0 true IL232851A0 (en) 2014-08-31

Family

ID=51418266

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232851A IL232851A0 (en) 2014-02-19 2014-05-28 Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases

Country Status (1)

Country Link
IL (1) IL232851A0 (en)

Similar Documents

Publication Publication Date Title
IL253945A0 (en) Kdm1a inhibitors for the treatment of disease
EP3212226A4 (en) Compositions and methods of use for treating metabolic disorders
EP3286311A4 (en) Method for the treatment of malignancies
EP3174894A4 (en) Compositions and methods of use for treating metabolic disorders
EP3377090A4 (en) Methods for treatment of bile acid-related disorders
ZA201703003B (en) Heparan sulfate biosynthesis inhibitors for the treatment of diseases
ZA201700183B (en) Acetylcholinesterase inhibitors for treatment of dermatological conditions
EP3504187A4 (en) Use of pridopidine for treating functional decline
IL257061A (en) Inhibitors of ezh2
IL254266B (en) Glucosylceramide synthase inhibitors for the treatment of diseases
EP3242947A4 (en) Method for the treatment of malignancies
EP3152195A4 (en) Mth1 inhibitors for treatment of cancer
PL3122349T3 (en) Compositions for the treatment of autodigestion
RS59313B1 (en) Orvepitant for the treatment of chronic cough
EP3108884A4 (en) Composition for prevention or treatment of treatment-resistant cancer
EP3091972A4 (en) Method of treating liver disorders
EP3200795A4 (en) Use of agents for treating fat-related disorders
EP3198054C0 (en) Surface treatment of metal substrates
IL232851A0 (en) Inhibitors of nadph oxidase 4 (nox4) for treating or alleviating chronic diseases
EP3157943A4 (en) Methods of treating or ameliorating migraine
AU2014904579A0 (en) Compositions and methods for treatment or prophylaxis of a liver condition
GB201416545D0 (en) Novel Method For Treatment Of Substrates
GB201421812D0 (en) New therapeutic uses of enzyme inhibitors
GB201410529D0 (en) New therapeutic uses of enzyme inhibitors